AFINITOR

Brand name authorized in: Austria Australia Brazil Canada Cyprus Spain Finland France Hong Kong Ireland Lithuania Netherlands New Zealand Poland Singapore Tunisia United Kingdom United States South Africa

Active ingredients

The drug AFINITOR contains one active pharmaceutical ingredient (API):

1 Everolimus
UNII 9HW64Q8G6G - EVEROLIMUS

Everolimus is a selective mTOR (mammalian target of rapamycin) inhibitor. mTOR is a key serine-threonine kinase, the activity of which is known to be upregulated in a number of human cancers.

Read about Everolimus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Everolimus
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
Discover more medicines within L01EG02

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 10131F, 10132G, 10133H, 10135K, 11254H, 11257L, 11258M, 11262R, 11267B, 11362B, 11377T, 11591C, 11592D, 11598K, 11599L, 11607X, 11608Y, 2818H, 2819J, 2985D
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 526530901116312, 526530902112310, 526530903119319
CA
Health Products and Food Branch
Identifier(s): 02339501, 02339528, 02369257, 02425645, 02425653, 02425661
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 09538001, 09538004
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 044580, 044591, 548899
FR
Base de données publique des médicaments
Identifier(s): 62142469, 64201368, 69867865
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 160557, 160562, 241043, 392269, 392271
HK
Department of Health Drug Office
Identifier(s): 59060, 59061, 61710, 63764, 63765, 63766
IE
Health Products Regulatory Authority
Identifier(s): 88009, 88304, 88305
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1050728, 1050730, 1050731, 1050733, 1070279, 1070280, 1070281, 1070282
NL
Z-Index G-Standaard, PRK
Identifier(s): 100471, 92568, 92576
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 13653, 13654, 14805
PL
Rejestru Produktów Leczniczych
Identifier(s): 100211716, 100211722, 100295200
SG
Health Sciences Authority
Identifier(s): 13749P, 13750P, 14130P
TN
Direction de la Pharmacie et du Médicament
Identifier(s): 10283341H, 10283342H
US
FDA, National Drug Code
Identifier(s): 0078-0566, 0078-0567, 0078-0594, 0078-0620, 0078-0626, 0078-0627, 0078-0628